Savient Hid Cash Woes Before Ch. 11 Sale, Investors Say
Investors in bankrupt Savient Pharmaceuiticals Inc. on Wednesday hit the drug developer's officers and directors with a shareholder class action in Delaware federal court, claiming Savient misrepresented its financial condition before...To view the full article, register now.
Already a subscriber? Click here to view full article